Personal-Care Ingredient News In Brief: UC Berkeley Study Makes Waves; PFAS In Cosmetics; More

Girls with elevated urinary concentrations of methyl paraben and propyl paraben biomarkers at age nine showed signs of entering puberty earlier than their peers, according to a UC Berkeley study focused on possible adverse impacts of personal-care product use. More news in brief.     

Investigators at the University of California, Berkeley’s Center for Environmental Research and Children’s Health say their longitudinal study published Dec. 4 in Human Reproduction suggests links between in utero or peripubertal exposure to personal-care ingredients – namely phthalates, parabens and other phenols – and altered pubertal timing in girls. The study followed 338 children from before birth to adolescence, finding signs of earlier puberty onset in the daughters of mothers who had higher levels of triclosan and 2,4-dichlorophenol biomarkers in their urine while pregnant. Accelerated pubertal developments also were observed in girls with relatively high urinary concentrations of methyl paraben and propyl paraben, as measured at age nine. The authors note limitations to their research, including the assessed chemicals’ rapid metabolization, such that “one or two urinary measurements per developmental point may not accurately reflect usual exposure.” Further, they accept that noted associations could reflect reverse causality – i.e., “children going through puberty early may be more likely to use personal-care products.” Regardless, the study is receiving wide media attention, doing no favors for the ingredients’ already shady reputations.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Ingredients & Safety

Plenty For Industry To Do As EU Wastewater Directive Faces Legal Challenges

 
• By 

Engaging with EU member state legislators, stressing the impact of national EPR systems on the accessibility, availability, and affordability of medicines, reformulating products to reduce their financial contribution, and lobbying for expanding the scope of EPR schemes to include other polluting industries are all ways that the European consumer health industry can try and influence the way that the revised Urban Wastewater Treatment Directive is transposed into national legislation, law firm Mason Hayes & Curran explains.

French Agency Proposes Effective EU Ban On CBD In Foods And Cosmetics

 
• By 

France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.

German Industry Urges ECHA To Reconsider ‘De Facto’ EU Ethanol Ban

 
• By 

Reclassifying ethanol as a carcinogenic, mutagenic, or reprotoxic substance - something the European Chemicals Agency seems likely to do in the near future - would be “tantamount to a de facto ban” with “fatal consequences” for medical care in Germany, says Pharma Deutschland in a joint paper with 13 other German healthcare industry associations.

AESGP: ‘No Evidence’ Of Antimicrobial Resistance With OTC Antifungals Or Antivirals

 
• By 

Two AESGP papers reviewing the evidence for AMR risk associated with a range of OTC antifungals and antivirals conclude there is litte to no risk associated with the responsible self-care use of such medicines.

More from HBW Insight

Makary Suggests Combining All FDA Adverse Event Reporting Systems

 

In discussing FDA’s adverse event monitoring, Makary also seemed to falsely imply the agency did not fully investigate the myocarditis signal with COVID-19 vaccines.

US Plans End To Petroleum-Based Dyes In Food

 

HHS Secretary Robet F. Kennedy Jr. and FDA Commissioner Marty Makary to announce planned changes as “a major step forward” as part of Kennedy’s “Make America Healthy Again” campaign President Trump has adopted for his administration.

Revlon Names North American President As Shiseido America CEO Resigns; Beauty News Roundup

 

Revlon Group Holdings LLC announces Dana Medema, formerly VP and head of Personal Health in North America for Philips, will serve as president, North America. Separately, Shiseido Company, Ltd. reports Ron Gee has resigned as Americas Region CEO and will be replaced on an interim basis by Alberto Noe.